Class information for:
Level 1: TFPI 2//TISSUE FACTOR PATHWAY INHIBITOR 2//AMBLYOMIN X

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
15956 682 29.4 53%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
17 4 REPRODUCTIVE BIOLOGY//OBSTETRICS & GYNECOLOGY//VETERINARY SCIENCES 563730
193 3       PREECLAMPSIA//OBSTETRICS & GYNECOLOGY//REPRODUCTIVE BIOLOGY 54114
3338 2             GLYCODELIN//PREGNANCY ASSOCIATED PLASMA PROTEIN A//TFPI 2 1773
15956 1                   TFPI 2//TISSUE FACTOR PATHWAY INHIBITOR 2//AMBLYOMIN X 682

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TFPI 2 authKW 1637351 7% 76% 48
2 TISSUE FACTOR PATHWAY INHIBITOR 2 authKW 959952 4% 79% 27
3 AMBLYOMIN X authKW 492491 2% 100% 11
4 PREGNANCY SPECIFIC GLYCOPROTEIN authKW 365626 2% 58% 14
5 TISSUE FACTOR PATHWAY INHIBITOR 2 TFPI 2 authKW 102332 1% 57% 4
6 ARCHIVES OF GYNECOLOGY journal 90362 4% 7% 27
7 ANTITUMOR DRUG CANDIDATE authKW 89544 0% 100% 2
8 CENTD address 89544 0% 100% 2
9 HUMAN TISSUE FACTOR PATHWAY INHIBITOR 2 authKW 89544 0% 100% 2
10 IMMUNOCHEMICAL QUANTITATION authKW 89544 0% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Obstetrics & Gynecology 5989 29% 0% 195
2 Reproductive Biology 1997 11% 0% 74
3 Oncology 508 16% 0% 108
4 Medical Laboratory Technology 462 5% 0% 31
5 Developmental Biology 411 5% 0% 36
6 Biochemistry & Molecular Biology 252 20% 0% 135
7 Medicine, Research & Experimental 190 7% 0% 50
8 Biophysics 151 6% 0% 44
9 Hematology 87 4% 0% 29
10 Peripheral Vascular Diseases 42 3% 0% 21

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CENTD 89544 0% 100% 2
2 MINIST EDUC MED SCISHANGHAI MED 59695 0% 67% 2
3 AFFILIATED CLIN WUHAN 44772 0% 100% 1
4 BIOTECHNOL CHEM SCI TECHNOL 44772 0% 100% 1
5 CELL BIOL KIHARA BIOL TOTSUKA KU 44772 0% 100% 1
6 CELL MOL BIOLSTATE MOL ONCOL 44772 0% 100% 1
7 CELLULAR MOL BIOL MEGURO KU 44772 0% 100% 1
8 EA 3249 CELLULES HEMATOPOIET HEMOSTASE GREFFE 44772 0% 100% 1
9 EQUINE BAD SAAROW 44772 0% 100% 1
10 EXPT ONCOL MED INVEST 44772 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ARCHIVES OF GYNECOLOGY 90362 4% 7% 27
2 ONCODEVELOPMENTAL BIOLOGY AND MEDICINE 45703 2% 9% 12
3 PLACENTA 10257 4% 1% 30
4 TUMOUR BIOLOGY 8133 1% 5% 4
5 BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY 5574 4% 1% 25
6 RICERCA IN CLINICA E IN LABORATORIO 3225 1% 1% 6
7 BIOORGANICHESKAYA KHIMIYA 2671 2% 0% 14
8 CLINICS IN OBSTETRICS AND GYNAECOLOGY 2479 1% 1% 4
9 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION C-IMMUNOLOGY 1654 0% 2% 2
10 EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY 1542 1% 0% 10

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 TFPI 2 1637351 7% 76% 48 Search TFPI+2 Search TFPI+2
2 TISSUE FACTOR PATHWAY INHIBITOR 2 959952 4% 79% 27 Search TISSUE+FACTOR+PATHWAY+INHIBITOR+2 Search TISSUE+FACTOR+PATHWAY+INHIBITOR+2
3 AMBLYOMIN X 492491 2% 100% 11 Search AMBLYOMIN+X Search AMBLYOMIN+X
4 PREGNANCY SPECIFIC GLYCOPROTEIN 365626 2% 58% 14 Search PREGNANCY+SPECIFIC+GLYCOPROTEIN Search PREGNANCY+SPECIFIC+GLYCOPROTEIN
5 TISSUE FACTOR PATHWAY INHIBITOR 2 TFPI 2 102332 1% 57% 4 Search TISSUE+FACTOR+PATHWAY+INHIBITOR+2+TFPI+2 Search TISSUE+FACTOR+PATHWAY+INHIBITOR+2+TFPI+2
6 ANTITUMOR DRUG CANDIDATE 89544 0% 100% 2 Search ANTITUMOR+DRUG+CANDIDATE Search ANTITUMOR+DRUG+CANDIDATE
7 HUMAN TISSUE FACTOR PATHWAY INHIBITOR 2 89544 0% 100% 2 Search HUMAN+TISSUE+FACTOR+PATHWAY+INHIBITOR+2 Search HUMAN+TISSUE+FACTOR+PATHWAY+INHIBITOR+2
8 IMMUNOCHEMICAL QUANTITATION 89544 0% 100% 2 Search IMMUNOCHEMICAL+QUANTITATION Search IMMUNOCHEMICAL+QUANTITATION
9 MATRIX ASSOCIATED SERINE PROTEASE INHIBITOR 89544 0% 100% 2 Search MATRIX+ASSOCIATED+SERINE+PROTEASE+INHIBITOR Search MATRIX+ASSOCIATED+SERINE+PROTEASE+INHIBITOR
10 PLACENTAL PROTEIN 5 89544 0% 100% 2 Search PLACENTAL+PROTEIN+5 Search PLACENTAL+PROTEIN+5

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 SIERKO, E , WOJTUKIEWICZ, MZ , KISIEL, W , (2007) THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR-2 IN CANCER BIOLOGY.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 33. ISSUE 7. P. 653-659 49 57% 43
2 CHAND, HS , FOSTER, DC , KISIEL, W , (2005) STRUCTURE, FUNCTION AND BIOLOGY OF TISSUE FACTOR PATHWAY INHIBITOR-2.THROMBOSIS AND HAEMOSTASIS. VOL. 94. ISSUE 6. P. 1122-1130 47 57% 47
3 MOORE, T , DVEKSLER, GS , (2014) PREGNANCY-SPECIFIC GLYCOPROTEINS: COMPLEX GENE FAMILIES REGULATING MATERNAL-FETAL INTERACTIONS.INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. VOL. 58. ISSUE 2-4. P. 273 -280 38 52% 8
4 RAN, YL , PAN, J , HU, H , ZHOU, Z , SUN, LC , PENG, L , YU, L , SUN, LX , LIU, J , YANG, ZH , (2009) A NOVEL ROLE FOR TISSUE FACTOR PATHWAY INHIBITOR-2 IN THE THERAPY OF HUMAN ESOPHAGEAL CARCINOMA.HUMAN GENE THERAPY. VOL. 20. ISSUE 1. P. 41-49 26 81% 17
5 IOCHMANN, S , BLECHET, C , CHABOT, V , SAULNIER, A , AMINI, A , GAUD, G , GRUEL, Y , REVERDIAU, P , (2009) TRANSIENT RNA SILENCING OF TISSUE FACTOR PATHWAY INHIBITOR-2 MODULATES LUNG CANCER CELL INVASION.CLINICAL & EXPERIMENTAL METASTASIS. VOL. 26. ISSUE 5. P. 457 -467 37 58% 12
6 SORENSEN, S , (1984) PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN (SP1) - PURIFICATION, CHARACTERIZATION, QUANTIFICATION AND CLINICAL-APPLICATION IN MALIGNANCIES - (A REVIEW).TUMOUR BIOLOGY. VOL. 5. ISSUE 6. P. 275-302 65 83% 44
7 LAI, YH , HE, RY , CHOU, JL , CHAN, MWY , LI, YF , TAI, CK , (2014) PROMOTER HYPERMETHYLATION AND SILENCING OF TISSUE FACTOR PATHWAY INHIBITOR-2 IN ORAL SQUAMOUS CELL CARCINOMA.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 12. ISSUE . P. - 28 61% 3
8 WILLIAMS, JM , BALL, M , WARD, A , MOORE, T , (2015) PSG22 EXPRESSION IN MOUSE TROPHOBLAST GIANT CELLS IS ASSOCIATED WITH GENE INVERSION AND CO-EXPRESSION OF ANTISENSE LONG NON-CODING RNAS.REPRODUCTION. VOL. 149. ISSUE 1. P. 125 -137 31 53% 0
9 XU, Y , QIN, XL , ZHOU, JJ , TU, ZG , BI, X , LI, WX , FAN, XQ , ZHANG, Y , (2011) TISSUE FACTOR PATHWAY INHIBITOR-2 INHIBITS THE GROWTH AND INVASION OF HEPATOCELLULAR CARCINOMA CELLS AND IS INACTIVATED IN HUMAN HEPATOCELLULAR CARCINOMA.ONCOLOGY LETTERS. VOL. 2. ISSUE 5. P. 779-783 24 71% 3
10 ZHANG, Q , ZHANG, Y , WANG, SZ , WANG, N , JIANG, WG , JI, YH , ZHANG, SL , (2012) REDUCED EXPRESSION OF TISSUE FACTOR PATHWAY INHIBITOR-2 CONTRIBUTES TO APOPTOSIS AND ANGIOGENESIS IN CERVICAL CANCER.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. VOL. 31. ISSUE . P. - 23 72% 2

Classes with closest relation at Level 1


Rank Class id link
1 34503 AACD DIAGNOST RADIOL//MARKER STATUS IN CYSTS//RESIDUAL CYSTS
2 17608 PREGNANCY ASSOCIATED PLASMA PROTEIN A//PAPP A//PAPPALYSIN
3 19525 GLYCODELIN//PLACENTAL PROTEIN 14//PP14
4 7780 CEACAM1//BILIARY GLYCOPROTEIN//CEACAM6
5 37693 GERMAN STAND//HERLEV HOSP GYNECOL OBSTET//ENZYME AMPLIFICATION ASSAY
6 15864 MED OBSTET GYNECOL1150 FUKUSHIMA//HCG SECRETION//GNRH BINDING PROTEIN
7 37414 EXCESS THYMIDINE//5 BROMODEOXYURIDINE//5 BROMODEOXYURIDINE IMMORTAL
8 31382 6 SULFANILAMIDOINDAZOLE//PHYSIOL ROSWELL PK//ALPHA2 PREGNANCY ASSOCIATED GLYCOPROTEIN
9 16953 PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2//PAI 2//SERPINB2
10 942 TISSUE FACTOR//TISSUE FACTOR PATHWAY INHIBITOR//TFPI

Go to start page